Reviews push pet food functional ingredients toward clearer science

Two recent review papers suggest companion animal nutrition is entering a more precise phase, where “functional ingredients” are being discussed less as a catch-all marketing term and more as a framework for targeted dietary interventions. The review in Veterinary Research Communications by Guo, Farooq, and Liu examines how functional ingredients, bioactive compounds, and supplements are defined in pet nutrition, while a companion review in Animals maps out plant-derived ingredients by phytochemical class and proposed mechanism of action in dogs and cats. Together, they reflect a broader shift in the field: commercial pet food is increasingly being evaluated not just for nutrient adequacy, but for whether specific compounds may influence inflammation, oxidative stress, the microbiome, metabolic health, and other physiologic endpoints. (mdpi.com)

That shift has been building for years. The WSAVA Global Nutrition Committee continues to emphasize evidence-based nutrition and cautions that ingredient lists alone can be misleading when evaluating food quality. Its nutrition resources focus attention on formulation, manufacturer expertise, and nutritional adequacy rather than unregulated front-of-pack ingredient narratives. At the same time, the research pipeline around functional feed for pets is visibly growing, including special-issue calls and reviews on plant extracts, immune-modulating phytonutrients, and alternative proteins. (wsava.org)

The underlying science is promising, but highly heterogeneous. The plant-focused Animals review describes polyphenols and other plant extracts as having antioxidant, anti-inflammatory, immunomodulatory, and microbiome-regulating effects, and points to microalgae and omega-3-rich sources as candidates for supporting lipid metabolism, cardiovascular function, and skin health. Related review literature also discusses ingredients such as yucca, chestnut tannins, curcumin, essential oils, and melatonin, but the strength of evidence varies substantially by ingredient, indication, species, and formulation. Several reviews explicitly say the field is still early, with limited in vivo and clinical data in dogs and cats. (mdpi.com)

Research interest is also being shaped by commercial and sustainability trends. A recent review of alternative proteins in pet food notes growing attention to plant, aquatic, insect, and cell-based sources, with reported interest in digestibility, palatability, microbiome effects, and immune benefits, especially for algae-derived inputs. Another recent labeling study of European dog foods suggests plant-based and hybrid products can pose practical formulation challenges, particularly around protein and fat profiles. In other words, the move toward bioactive and functional ingredients is happening alongside broader experimentation in what goes into commercial pet food and how those products are positioned. (mdpi.com)

Expert commentary from major veterinary nutrition bodies remains cautious rather than dismissive. WSAVA’s nutrition materials stress that ingredient presence does not, by itself, establish diet quality or clinical benefit, a point that matters as functional claims proliferate. That caution is echoed in review literature on canine immune support and plant extracts, which repeatedly calls for better standardization, clearer dosing, and stronger trial design before broad conclusions are made. The likely direction of travel is not away from functional ingredients, but toward tighter evidence thresholds for how they’re used and discussed. (wsava.org)

Why it matters: For veterinary professionals, these reviews are useful because they help organize a fast-growing, and sometimes confusing, category. They offer a vocabulary for discussing when an ingredient is simply part of a formula, when it may have a plausible biologic effect, and when there’s enough evidence to support a clinical recommendation. That distinction matters in practice, especially as pet parents ask more questions about gut health, inflammation, cognition, skin support, immune resilience, and “natural” additives. The practical message is to stay anchored in complete-and-balanced nutrition, evaluate manufacturer evidence critically, and treat most functional ingredients as adjuncts with varying levels of support rather than as stand-alone solutions. (wsava.org)

There’s also a regulatory and communication angle. As functional ingredients become more common, veterinary teams may increasingly need to interpret claims that sound scientific but rest on limited species-specific data. That includes questions about label language, extrapolation from human or livestock studies, batch-to-batch consistency of plant extracts, and whether a given inclusion level is meaningful in a finished diet. Reviews in this area consistently point to those gaps, which suggests demand for better substantiation is likely to grow across both clinical and commercial settings. (mdpi.com)

What to watch: The next phase will likely be less about identifying new candidate ingredients and more about validating them, with more species-specific trials, clearer claim substantiation, and closer scrutiny of how functional compounds are incorporated into complete commercial diets. That’s an inference based on the direction of current review literature and industry research activity. (mdpi.com)